Ashu Tyagi - Net Worth and Insider Trading

Ashu Tyagi Net Worth

The estimated net worth of Ashu Tyagi is at least $17 Million dollars as of 2024-05-12. Ashu Tyagi is the Director of Y-mAbs Therapeutics Inc and owns about 1,392,740 shares of Y-mAbs Therapeutics Inc (YMAB) stock worth over $17 Million. Details can be seen in Ashu Tyagi's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Ashu Tyagi has not made any transactions after 2018-09-25 and currently still holds the listed stock(s).

Transaction Summary of Ashu Tyagi

To

Ashu Tyagi Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Ashu Tyagi owns 1 companies in total, including Y-mAbs Therapeutics Inc (YMAB) .

Click here to see the complete history of Ashu Tyagi’s form 4 insider trades.

Insider Ownership Summary of Ashu Tyagi

Ticker Comapny Transaction Date Type of Owner
YMAB Y-mAbs Therapeutics Inc 2018-09-25 director

Ashu Tyagi Latest Holdings Summary

Ashu Tyagi currently owns a total of 1 stock. Ashu Tyagi owns 1,392,740 shares of Y-mAbs Therapeutics Inc (YMAB) as of September 25, 2018, with a value of $17 Million.

Latest Holdings of Ashu Tyagi

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
YMAB Y-mAbs Therapeutics Inc 2018-09-25 1,392,740 12.28 17,102,847

Holding Weightings of Ashu Tyagi


Ashu Tyagi Form 4 Trading Tracker

According to the SEC Form 4 filings, Ashu Tyagi has made a total of 0 transactions in Y-mAbs Therapeutics Inc (YMAB) over the past 5 years. The most-recent trade in Y-mAbs Therapeutics Inc is the acquisition of 430,174 shares on September 25, 2018, which cost Ashu Tyagi around $7 Million.

Insider Trading History of Ashu Tyagi

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Ashu Tyagi Trading Performance

GuruFocus tracks the stock performance after each of Ashu Tyagi's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Ashu Tyagi is -39.04%. GuruFocus also compares Ashu Tyagi's trading performance to market benchmark return within the same time period. The performance of stocks bought by Ashu Tyagi within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Ashu Tyagi's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Ashu Tyagi

Average Return

Average return per transaction

Outperforming Transactions

1 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -6.05
Relative Return to S&P 500(%) 1.15

Ashu Tyagi Ownership Network

Ownership Network List of Ashu Tyagi

No Data

Ownership Network Relation of Ashu Tyagi


Ashu Tyagi Owned Company Details

What does Y-mAbs Therapeutics Inc do?

Who are the key executives at Y-mAbs Therapeutics Inc?

Ashu Tyagi is the director of Y-mAbs Therapeutics Inc. Other key executives at Y-mAbs Therapeutics Inc include director & President and Chairman Thomas Gad , SVP and CMO Vignesh Rajah , and Senior Vice President & CCO Susan Laura Smith .

Y-mAbs Therapeutics Inc (YMAB) Insider Trades Summary

Over the past 18 months, Ashu Tyagi made no insider transaction in Y-mAbs Therapeutics Inc (YMAB). Other recent insider transactions involving Y-mAbs Therapeutics Inc (YMAB) include a net purchase of 380,768 shares made by Biotech Aps Wg , a net purchase of 380,768 shares made by Johan Wedell-wedellsborg , and a net sale of 303,900 shares made by Thomas Gad .

In summary, during the past 3 months, insiders sold 7,293 shares of Y-mAbs Therapeutics Inc (YMAB) in total and bought 0 shares, with a net sale of 7,293 shares. During the past 18 months, 307,293 shares of Y-mAbs Therapeutics Inc (YMAB) were sold and 762,731 shares were bought by its insiders, resulting in a net purchase of 455,438 shares.

Y-mAbs Therapeutics Inc (YMAB)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Y-mAbs Therapeutics Inc Insider Transactions

No Available Data

Ashu Tyagi Mailing Address

Above is the net worth, insider trading, and ownership report for Ashu Tyagi. You might contact Ashu Tyagi via mailing address: Scopia Capital Management Lp, 152 West 57th Street, 33rd Floor, New York Ny 10019.

Discussions on Ashu Tyagi

No discussions yet.